
    
      Protocol Summary:

      Prospective, randomized, controlled, unblinded, post-market, single-center clinical study

      Objectives:

      Patients treated with the BioSentry system will be compared to patients not treated with the
      BioSentry System (Control Group).

      Primary Objective:

      Evaluate the rate of chest tube placement after percutaneous transthoracic needle lung biopsy

      Secondary Objectives:

      Evaluate the rate of intra-procedural pneumothorax Evaluate the rate of post-procedural
      pneumothorax Evaluate cost associated with complications Evaluate the number of hospital
      admissions
    
  